aqx-1125
Small moleculeexperimental
Clinical trial activity
7 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
5
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2013 (NCT01882543)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- (1s,3s,4r)-4-((3as,4r,5s,7as)-4-(aminomethyl)-7a-methyl-1-methylidene-octahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol acetic acid salt
- 4-(4-(aminomethyl)-7a-methyl-1-methylideneoctahydro-1h-inden-5-yl)-3-(hydroxymethyl)-4-methylcyclohexan-1-ol
- aqx-1125
- aqx-1125
- aqx-1125
- aqx-1125
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03500159 | Phase 2 | Apr 18, 2018 | Aquinox Pharamceuticals Inc, The Cleveland Clinic |
| NCT03478020 | Phase 1 | Nov 22, 2017 | Aquinox Pharamceuticals Inc, Pharmaceutical Research Associates, Inc. (PRA) |
| NCT03185195 | Phase 1 | Nov 22, 2016 | Aquinox Pharamceuticals Inc, Quotient |
| NCT02858453 | Phase 3 | Jul 1, 2016 | Aquinox Pharamceuticals Inc, Hofstra University |
| NCT02324972 | Phase 2 | Dec 1, 2014 | Aquinox Pharamceuticals Inc, Innovaderm |
| NCT01954628 | Phase 2 | Oct 1, 2013 | Aquinox Pharamceuticals Inc |
| NCT01882543 | Phase 2 | Jun 1, 2013 | Aquinox Pharamceuticals Inc |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aquinox Pharamceuticals Inc | For profit | 7 | 7 | 3 | 2013 |
| Hofstra University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Innovaderm | For profit | 1 | 0 | 1 | 2014 |
| Pharmaceutical Research Associates, Inc. (PRA) | For profit | 1 | 0 | 1 | 2017 |
| Quotient | For profit | 1 | 0 | 1 | 2016 |
| The Cleveland Clinic | Academic/Hospital | 1 | 0 | 1 | 2018 |
6 organizations
Page 1 / 1